JOPIC

The JoPIC is an independent-unbiased, peer-reviewed, and open-access journal of current national and international issues and reviews for original clinical and experimental research, interesting case reports, surgical techniques, differential diagnoses, editorial opinions, letters to the editor, and educational papers in pulmonology, thoracic surgery, occupational diseases, allergology, and intensive care medicine.

EndNote Style
Index
Case Report
Pandoraea spp. infection in the course of post-COVID pulmonary fibrosis: a rare case report
Pandoraea species are rare, Gram-negative, aerobic bacilli classified in the Burkholderiaceae family. They are increasingly recognized as pathogens in both cystic fibrosis (CF) and non-CF patients, frequently associated with chronic pulmonary infections and multidrug resistance. These organisms can cause significant inflammatory responses and exacerbate pre-existing structural lung diseases. Case: A 32-year-old female with a history of allergic asthma presented with had worsening cough, shortness of breath, and fatigue following a COVID-19 infection. Chest computed tomography revealed bilateral fibrotic changes and cystic bronchiectasis, in addition to nodular lesions predominantly in the upper lobes. Bronchoscopy and bronchoalveolar lavage (BAL) were performed. In BAL culture, Pandoraea spp. exhibiting sensitivity to amikacin, cefepime, ciprofloxacin, gentamicin, piperacillin, aztreonam, and imipenem were identified. The patient was treated with ciprofloxacin for a month, resulting in significant clinical and radiological improvement and a reduction in inflammatory markers. Post-COVID pulmonary fibrosis can facilitate the proliferation of opportunistic bacterial infections. Pandoraea species can exacerbate chronic lung damage and inflammation thru biofilm formation and the induction of pro-inflammatory cytokines (IL-6, IL-8). This case highlights the importance of considering Pandoraea spp. as a potential cause of unresolved pulmonary infections, particularly in patients with pre-existing viral lung damage or bronchiectasis. Although rare, Pandoraea infections can complicate post-COVID pulmonary pathology and mimic chronic infection processes. Early microbiological identification and appropriate antimicrobial therapy are crucial for optimal patient outcomes.


1. Coenye T, Falsen E, Hoste B, et al. Description of Pandoraea gen. nov. with Pandoraea apista sp. nov., Pandoraea pulmonicola sp. nov., Pandoraea pnomenusa sp. nov., Pandoraea sputorum sp. nov. and Pandoraea norimbergensis comb. nov. Int J Syst Evol Microbiol. 2000;50 Pt 2:887-899. doi:10.1099/00207713-50-2-887
2. Degand N, Lotte R, Decondé Le Butor C, et al. Epidemic spread of Pandoraea pulmonicola in a cystic fibrosis center. BMC Infect Dis. 2015; 15:583. doi:10.1186/s12879-015-1327-8
3. Burns JL, Jonas M, Chi EY, Clark DK, Berger A, Griffith A. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect Immun. 1996;64(10):4054-4059. doi:10.1128/iai.64.10.4054-4059.1996
4. Cieri MV, Mayer-Hamblett N, Griffith A, Burns JL. Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect Immun. 2002;70(3):1081-1086. doi:10.1128/IAI.70. 3.1081-1086.2002
5. Duff C, Murphy PG, Callaghan M, McClean S. Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb Pathog. 2006;41(4-5):183-192. doi: 10.1016/j.micpath.2006.07.005
6. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis. 2002;8(2):181-187. doi:10.3201/eid0802.010163
7. Tabatabaei M, Dastbarsar M, Moslehi MA. Isolation and identification of Pandoraea spp. From bronchoalveolar lavage of cystic fibrosis patients in Iran. Ital J Pediatr. 2019;45(1):118. doi:10.1186/s13052-019-0687-x
8. Dupont C, Aujoulat F, Chiron R, Condom P, Jumas-Bilak E, Marchandin H. Highly diversified Pandoraea pulmonicola population during chronic colonization in cystic fibrosis. Front Microbiol. 2017;8:1892. doi:10.3389/fmicb.2017.01892
Volume 4, Issue 2, 2026
Page : 27-29
_Footer